Management
Michael McFadden, BBA
Mr. McFadden brings more than 30 years of successful leadership experience spanning pre-IND drug discovery through the commercialization and has launched over a dozen therapies in neurology, psychiatry, endocrinology and urology. He has over 16 years’ experience in Neuroscience. Previous leadership roles have included Chief Commercial Officer at MPower Health, Chief Commercial Officer at Urovant Sciences (Nasdaq: UROV), and SVP Sales and Marketing at Avanir Pharmaceuticals (Nasdaq: AVNR). Prior to these roles, Mr. McFadden held leadership roles at Amylin Pharmaceuticals (Nasdaq: AMLN) and Pharmacia. He serves on advisory boards at MPower Health and MindLab.
Lauren D'Angelo, MBA
Lauren D'Angelo, MBA
Ms. D’Angelo is a senior biopharmaceutical executive with 25 years of experience spanning corporate strategy, commercialization, operations, sales and marketing, and P&L leadership across 15 products and nine therapeutic areas. She has extensive experience leading organizations from pre-commercialization through launch and growth, building high-performing teams and commercial infrastructure, and developing U.S. and global commercialization strategies. Throughout her career, Ms. D’Angelo has developed and led more than 20 launch plans and successfully launched 16 products, new indications, and line extensions across a range of leadership roles. Ms. D’Angelo was named one of Fierce Pharma’s 2026 Fiercest Women in Life Sciences and a 2025 LifeSci Voice Top Industry Leader. Her previous honors include PharmaVoice’s 2023 PharmaVoice 100, MM+M’s 2022 Women of Distinction and 2017 Women to Watch, and Pharmaceutical Executive’s 2020 Emerging Pharma Leaders.
Henry Du, CPA
Henry Du, CPA
Mr. Du brings over 20 years' experience to Alpha Cognition in leadership roles in both finance and accounting. Prior to Mr. Du was Sr. Vice President of Accounting and Administration at Amplify Surgical, a medical device company focused on developing innovative endoscopic surgical techniques and spinal implant technologies, where he led the finance and accounting functions, as well as administrative roles including HR, payroll, compliance, corporate legal, and investor relations. During his tenure there, he was instrumental in helping the company achieve consistent positive EBIDTA and profitability, along with doubling average daily operating liquidity. Mr. Du was also VP of Finance and Senior Corporate Controller at HUYABIO International, a leader in globalizing Chinese pharmaceutical innovation, where he established the commercial accounting policy for the company's product launch in Japan. Prior to HUYABIO, Mr. Du served in leadership roles at Eledon Pharmaceuticals (formerly Novus Therapeutics), a publicly traded clinical-stage biopharmaceutical company, United Auto Credit, and at Avanir. He earned his B.A. in Economics-Accounting from Claremont McKenna College. Mr. Du is a licensed Certified Public Accountant (CPA) in the State of California.
Denis Kay, MSc, PhD
Denis Kay, MSc, PhD
Dr. Kay is the Co-founded the Company’s original company Neurodyn Life Sciences (NLS), in August 2006 and acted as NLS’s Chief Scientific Officer since that time. In 2017 he assumed the role of Chief Scientific Officer at ACI. He brings more than 30 years of experience in the development and characterization of animal models of neurological diseases, and 7 years of early-stage Central Nervous System clinical development experience in. He is a grant recipient of the Michael J. Fox Foundation and has received funding from numerous agencies for research and product development programs.




